Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4

Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4

Our group has previously demonstrated that short-term treatment with esmolol reduces left ventricular hypertrophy (LVH) in spontaneously hypertensive rats (SHRs). The present study aimed to assess the molecular mechanisms related to this effect. Fourteen-month-old male SHRs were treated intravenousl...

Full description

Bibliographic Details
Main Authors:	Begoña Quintana-Villamandos, David A. Goukassian, Sharath P. Sasi, Emilio Delgado-Baeza
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/2691014

Similar Items

Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy
by: Laia Pazó-Sayós, et al.
Published: (2020-08-01)

Short-Term Esmolol Improves Coronary Artery Remodeling in Spontaneously Hypertensive Rats through Increased Nitric Oxide Bioavailability and Superoxide Dismutase Activity
by: Ana Arnalich-Montiel, et al.
Published: (2014-01-01)

Plasma protein thiolation index (PTI) as a potential biomarker for left ventricular hypertrophy in humans.
by: Begoña Quintana-Villamandos, et al.
Published: (2019-01-01)

Esmolol for the treatment of recurrent ventricular tachycardia
by: Simone Savastano, et al.
Published: (2016-10-01)

Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand–Induced Osteoclastogenesis in Bone Marrow–Derived Macrophages Isolated from Sprague–Dawley Rats by Regulating NF-κB/NFATc1 and Akt/NFATc1 Signaling Pathways
by: Wei Wang, et al.
Published: (2021-02-01)

Esmolol Administration for the Treatment of Refractory Ventricular Fibrillation
by: Kazım KARAASLAN, et al.
Published: (2016-12-01)

The role of single nucleotide polymorphisms of NFATC genes in the development of left ventricular hypertrophy in primary arterial hypertensive adolescents
by: A.V. Tovma, et al.
Published: (2017-12-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
by: Zhenzhen Li, et al.
Published: (2019-01-01)

KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
by: Shu-Fen Liou, et al.
Published: (2013-01-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Esmolol Use in Dual Axis Defibrillation Resistant Ventricular Fibrillation
by: Ankit Agrawal, et al.
Published: (2020-01-01)

OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis
by: Begoña Quintana-Villamandos, et al.
Published: (2020-06-01)

Impact of a Multichannel Blocker in Attenuating Intramyocardial Artery Remodeling in Hypertensive Rats through Increased Nitric Oxide Bioavailability
by: Begoña Quintana-Villamandos, et al.
Published: (2019-01-01)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
by: Moo Rim Kang, et al.
Published: (2014-11-01)

Traumatic Refractory Ventricular Fibrillation Successfully Treated with Intra-Arrest Esmolol
by: Kevin Raymond, et al.
Published: (2021-10-01)

MIP-1δ activates NFATc1 and enhances osteoclastogenesis: involvement of both PLCγ2 and NFκB signaling.
by: Kristy L Weber, et al.
Published: (2012-01-01)

Esmolol for the treatment of refractory ventricular fibrillation: a systematic review and meta-analysis
by: Richard Armour, et al.
Published: (2020-01-01)

Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway
by: Xueying Tan, Jianping Li, Xinyue Wang, Nan Chen, Benzhi Cai, Gang Wang, Hongli Shan, Deli Dong, Yanju Liu, Xingda Li, Fan Yang, Xin Li, Peng Zhang, Xueqi Li, Baofeng Yang, Yanjie Lu
Published: (2011-01-01)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway
by: Jinchuan Yan, et al.
Published: (2015-01-01)

Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation
by: Ming Hu, et al.
Published: (2018-03-01)

Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs
by: Paloma Morillas-Sendín, et al.
Published: (2015-01-01)

The antinociceptive effect of esmolol
by: Yoon Hee Kim
Published: (2010-09-01)

Corrigendum to “Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs”
by: Paloma Morillas-Sendín, et al.
Published: (2016-01-01)

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
by: Mineko Tomomura, et al.
Published: (2015-01-01)

FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
by: Jia Sun, et al.
Published: (2020-10-01)

Comparison of the Potency of Pterostilbene with NF-κB Inhibitors in Platelet Activation: Mutual Activation by Akt-NF-κB Signaling in Human Platelets
by: Chih-Wei Hsia, et al.
Published: (2021-07-01)

OGDHL is a modifier of AKT-dependent signaling and NF-κB function.
by: Tanusree Sen, et al.
Published: (2012-01-01)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
by: Jeong-Mi Kim, et al.
Published: (2017-04-01)

PolyADP-Ribosylation of NFATc3 and NF-κB Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury
by: Yunjuan Nie, et al.
Published: (2020-10-01)

The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review
by: Dennis Miraglia, et al.
Published: (2020-03-01)

First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration
by: Kevin M Boehm, et al.
Published: (2016-11-01)

QRS Voltage-Duration Product in the Identification of Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats
by: Ljuba Bacharova, et al.
Published: (2002-08-01)

IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response
by: Junjie Zhang, et al.
Published: (2016-07-01)

Direct Effects of Esmolol and Landiolol on Cardiac Function, Coronary Vasoactivity, and Ventricular Electrophysiology in Guinea-Pig Hearts
by: Shigehiro Shibata, et al.
Published: (2012-01-01)

Nuclear factor of activated T-cells (NFATC) as a possible diagnostic and prognostic marker in congenital valvular diseases and myocardial hypertrophy
by: А. V. Kamenshchyk, et al.
Published: (2014-12-01)

The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension
by: T.A. Uggere, et al.
Published: (2000-05-01)

High-throughput analysis of NF-κB dynamics in single cells reveals basal nuclear localization of NF-κB and spontaneous activation of oscillations.
by: Samuel Zambrano, et al.
Published: (2014-01-01)

A possible role of NF-κB and HSP72 in skeletal muscle hypertrophy induced by heat stress
by: 大野, 善隆
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9fanfc0ur184l32qgketfpgvvl